A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma(Harvard University), Jeff Settleman(Discovery Centre), Nancy G. Azizian(The University of Texas MD Anderson Cancer Center), Michael A. Fischbach(Stanford University), Bihua Li(Massachusetts General Hospital), K. Brandstetter(Dana-Farber Cancer Institute), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Ultan McDermott(AstraZeneca (United Kingdom)), Diana Lee, Fumiyuki Takahashi(Juntendo University), Margaret P. Quinlan(Massachusetts General Hospital), Sridhar Ramaswamy(Harvard University), Kwok‐Kin Wong(NYU Langone Health), Marie Classon(Pfizer (United States)), Lee Zou(Duke University)
Cited by 2,769
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k